Added Value of Semi-quantitative Analysis in Interim FDG-PET/CT in Pediatric Lymphoma

The Role of Positron Emission Tomography/Computed Tomography (PET/CT) in Assessment of Therapeutic Response in Non-Hodgkin Lymphoma

Update of Assessment of Early Response Using PET/CT in Malignant Lymphoma.

Prognostic value of Baseline and interim Volume based PET parameters in prediction of early therapy response and survival in pediatric patients with bulky and advanced HL.

Value of qPET in Pediatric Patients with Hodgkin Lymphoma

Role of PET/CT in Monitoring Response in Treatment of Non-Hodgkin Lymphoma Patients

Predictive value of FDG PET/CT in pediatric Neuroblastoma patients

Role of FDG-PET/CT in Assessment of Response to Therapy in Breast Cancer Patients

The Role of 18F-FDG PET/CT in Follow up After Treatment in Childhood Langerhans Cell Histiocytosis.

Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma?